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ABSTRACT: Transmembrane chemotaxis receptors are
found in bacteria in extended hexagonal arrays stabilized by
the membrane and by cytosolic binding partners, the kinase
CheA and coupling protein CheW. Models of array
architecture and assembly propose receptors cluster into
trimers of dimers that associate with one CheA dimer and two
CheW monomers to form the minimal “core unit” necessary
for signal transduction. Reconstructing in vitro chemoreceptor
ternary complexes that are homogeneous and functional and
exhibit native architecture remains a challenge. Here we report that His-tag-mediated receptor dimerization with divalent metals
is sufficient to drive assembly of nativelike functional arrays of a receptor cytoplasmic fragment. Our results indicate receptor
dimerization initiates assembly and precedes formation of ternary complexes with partial kinase activity. Restoration of maximal
kinase activity coincides with a shift to larger complexes, suggesting that kinase activity depends on interactions beyond the core
unit. We hypothesize that achieving maximal activity requires building core units into hexagons and/or coalescing hexagons into
the extended lattice. Overall, the minimally perturbing His-tag-mediated dimerization leads to assembly of chemoreceptor arrays
with native architecture and thus serves as a powerful tool for studying the assembly and mechanism of this complex and other
multiprotein complexes.
Many fundamental biological processes are performed bymultiprotein complexes.1,2 To fully understand how
these processes occur within the cell, methods are needed both
for monitoring such processes in vivo and for isolation and/or
reassembly of such complexes for in vitro structure−function
analysis. Isolation and reassembly of complexes often require
modifications or deletions of portions of the protein
components: for instance, deletion of transmembrane domains
of membrane proteins may be needed to prepare homogeneous
complexes for structural or biophysical studies. Typically, such
truncations also delete stabilizing interactions, and it becomes
difficult to reassemble complexes with nativelike architecture
and activity. We have developed a novel strategy for the
stabilization of assemblies with native structure and activity for
in vitro mechanistic studies.
Bacterial chemotaxis receptors are an ideal system for
understanding the molecular details of signal transduction by
membrane proteins and their complexes. Chemotaxis receptors
are dimeric transmembrane proteins anchored in the inner
membrane in large patches at the poles of the cell, which are
responsible for sensing and responding to environmental
stimuli. When the ligand binds to the receptor periplasmic
domain, a signal is transmitted down the ∼300 Å length of the
receptor to control the autophosphorylation activity of an
associated histidine kinase, CheA, which plays a central role in
the signal transduction pathway. In addition to forming a
complex with CheA and a coupling protein CheW, receptors
form large clusters (a membrane surface area of 53000 nm2 for
Escherichia coli)3−5 that enable extraordinary levels of
cooperativity and sensitivity.6,7 The native system is built of
trimers of receptor dimers that each form one vertex of a
hexagon within the membrane and are stabilized at the
membrane-distal tip of the receptor by hexagonal rings of
alternating CheA and CheW.8−10 It is challenging to prepare
homogeneous samples of functional chemoreceptor complexes
in vitro for structure−function analysis. Complexes of the intact
membrane-bound receptor with CheA and CheW are not
homogeneous, in part because of the inability to control the
orientation of the receptor within membrane vesicles11,12 or
nanodiscs.13 In principle, the membrane orientation issue can
be addressed by using a cytoplasmic fragment of the receptor,
but this truncated construct does not form functional
complexes with CheA or CheW in solution. Presumably, this
is because the missing transmembrane and periplasmic domains
are needed to provide protein−protein interactions that
stabilize the receptor dimer and geometrical alignment within
the membrane that promotes assembly of the array.
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In an elegant combination of membrane mimetics and
nanoscale assembly tools, Weis and co-workers developed
templating vesicles that promote the assembly of membrane-
associated multiprotein complexes from soluble component
proteins. This technology harnesses the high-affinity interaction
between histidine imidazole groups and the Ni(II)-NTA
functional group originally developed for immobilized metal
affinity chromatography protein purification.14 The N-termi-
nally His-tagged cytoplasmic fragment (CF) of the aspartate
chemoreceptor binds to vesicles containing lipids with nickel-
chelating headgroups (DOGS-NTA), which enables binding of
CheA and CheW into ternary complexes with kinase and
methylation activity that mimic native signaling states.15,16
Molecular crowding agents such as PEG8000 provide an
alternate means of driving assembly of functional complexes,
with no requirement for membrane vesicles.17 Both assembly
methods result in extended hexagonal arrays with nativelike
architecture,12 and PEG-mediated assembly forms sandwich
lattices remarkably similar to cytoplasmic chemoreceptor arrays
seen in some bacterial species.18,19
Here we report a novel method for assembling functional
arrays in vitro and for monitoring the stages of assembly. We
show that adding divalent metal salts to ternary mixtures of His-
tagged CF, CheA, and CheW promotes receptor dimerization
and assembly into active complexes with native stoichiometry
and architecture. Moreover, kinetic analysis with this new
assembly method provides the first experimental evidence that
initial binding of CheA and CheW into ternary complexes
proposed to be the “core unit” does not yield high activity, and
that activity reaches its maximum upon formation of larger
arrays. His-tag-mediated dimerization provides a new approach
to stabilizing multiprotein assemblies for analysis of protein
mechanisms within their native complexes.
■ MATERIALS AND METHODS
Vesicle Preparation. DOPC (1,2-dioleoyl-sn-glycero-3-
phosphocholine) and the nickel-chelating lipid DOGS-NTA-
Ni2+ (1,2-dioleoyl-sn-glycero-3-{[N-(5-amino-1-carboxypentyl)-
iminodiacetic acid]succinyl}) (Avanti Polar Lipids) were
combined in chloroform at a 1.5:1 DOPC:DOGS-NTA-Ni2+
molar ratio. Lipids were dried into a thin film with a stream of
N2 gas and left under a vacuum for 1 h before being rehydrated
with 1× PKB {phosphate kinase buffer [50 mM KxHxPO4 (pH
7.5), 50 mM KCl, and 5 mM MgCl2]} and vortexed extensively
(30 s vortex, 5 min rest, repeated three times) to form
multilamellar vesicles, followed by five cycles of 3 min freezing/
thawing. Freeze/thaw cycles were accomplished by dipping the
lipids in liquid nitrogen for 20 s to freeze and left on the bench
for 3 min and then held for 3 min in a 37 °C water bath.
Extrusion was then performed with an extrusion apparatus
(Avanti Polar Lipids) using a 100 nm diameter pore size
polycarbonate membrane. High-concentration stocks at 3 mM
total lipid (1.8 mM DOPC and 1.2 mM DOGS-NTA-Ni2+)
were prepared, and a final [lipid]total of 725 μM was used for
assembly (see below). The lipid concentrations were optimized
in parallel with CheA and CheW concentrations to maximize
kinase activity under conditions under which the available
vesicle surface area could accommodate all CF as hexagonal
arrays.
Plasmid Construction. The pHTCF4Q plasmid encoding
the cytoplasmic fragment (CF) of the aspartate chemoreceptor
with glutamine at all four primary methylation sites (4Q) was
isolated from DH5αF′ E. coli cells.20 A TEV-protease (tobacco
etch virus) recognition and cleavage sequence (ENLYFQG)
was inserted directly following the N-terminal His6-tag of
pHTCF4Q using site-directed mutagenesis and polymerase
chain reaction (PCR). Forward (5′-GAAAACCTGTATTTT-
CAGGGCGGATCCCCTATGCAACG-3′) and reverse (5′-
GCCCTGAAAATACAGGTTTTCGTGATGGTGATGGT-
GATG-3′) overlapping primers were designed to include the
TEV-protease recognition sequence and were purchased from
Eurofins Genomics. The PCR was performed in a thermocycler
(Bio-Rad MJ Mini), and reagents, including Phusion DNA
polymerase, dNTPs, and DpnI, were purchased from New
England Biolabs. The PCR product (pTEVCF4Q, ampR) was
subjected to DpnI digestion and transformed into DH5αF′ for
plasmid purification. Following sequence verification (Gene-
wiz), pTEVCF4Q was co-transformed with pCF430 (encoding
lacIq and tetR) into BL21(DE3) for protein expression.
Protein Purification. BL21(DE3) E. coli cells expressing
H6CF (pHTCF4Q, amp
R) or H6TEV-CF (pTEVCF4Q, amp
R)
co-transformed with pCF430 (tetR) were grown in Luria-
Bertani (LB) broth with ampicillin (100 μg/mL) and
tetracycline (10 μg/mL) at 37 °C until the optical density at
600 nm reached approximately 0.6. The temperature was
decreased to 15 °C for induction with 1 mM IPTG for 16−18
h. Cells were pelleted, resuspended in lysis buffer [75 mM
KxHxPO4 (pH 7.5), 500 mM NaCl, 5 mM imidazole, and 1
mM EDTA], and lysed with a microfluidizer at 16K psi. PMSF
(1 mM) was added every hour following cell lysis to limit
proteolysis. Cell debris was separated by centrifugation and the
supernatant applied to a HisTrap FF Ni2+-NTA affinity column
(GE Healthcare) equilibrated with 10 column volumes of 75
mM KxHxPO4 (pH 7.5), 500 mM NaCl, and 5 mM imidazole.
The column was washed with 5 column volumes of 75 mM
KxHxPO4 (pH 7.5), 500 mM NaCl, and 50 mM imidazole,
before elution with 75 mM KxHxPO4 (pH 7.5), 500 mM NaCl,
and 500 mM imidazole. Eluted protein was verified by SDS−
PAGE, and fractions were pooled prior to treatment with 5 mM
EDTA to chelate any Ni2+ stripped from the column and
dialysis against 75 mM KxHxPO4 (pH 7.5) and 75 mM KCl
with 7 kDa molecular weight cutoff SnakeSkin tubing (Thermo
Scientific) to remove EDTA and imidazole and lower the NaCl
concentration. Half of the purified H6TEV-CF was subjected to
His-tag removal by TEV-protease cleavage (details below).
Plasmids encoding TEV-cleavable His-tagged CheA (pTEV-
cheA, kanR), CheW (pTEVcheW, kanR), and CheY (pTEV-
cheY, kanR) (plasmid construction details described else-
where)21 were expressed in BL21(DE3) and grown at 37 °C
in LB broth supplemented with 50 μg/mL kanamycin. At an
optical density at 600 nm of ∼0.7−0.9, 1 mM IPTG was added
to induce expression for 3 h before the cells were harvested and
purified with HisTrap affinity chromatography as described for
CF above. A different buffer system for CheA, CheW, and
CheY purification was used: lysis buffer [75 mM Tris-HCl (pH
7.4), 100 mM KCl, and 1 mM EDTA], equilibration buffer [75
mM Tris-HCl (pH 7.4) and 100 mM KCl], wash buffer [75
mM Tris-HCl (pH 7.4), 100 mM KCl, and 10 mM imidazole],
and elution buffer [75 mM Tris-HCl (pH 7.4), 100 mM KCl,
and 250 mM imidazole]. Following elution, fractions
containing protein were verified by SDS−PAGE, pooled and
treated with 5 mM EDTA, and then dialyzed as for CF into 75
mM Tris-HCl (pH 7.4) and 100 mM KCl prior to His-tag
removal.
Plasmid pRK793 (ampR) encoding N-terminally His-tagged
TEV-protease (a gift from D. Waugh, Addgene plasmid 8827)22
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was expressed in BL21(DE3)-RIL (ampR). Cells were grown at
37 °C in LB broth containing 150 μg/mL ampicillin and 50 μg/
mL chloramphenicol. Protein production was induced at 30 °C
with 1 mM IPTG for 4 h when an optical density of 0.6 was
reached. The protein purification protocol and buffer system
for CheA, CheW, and CheY was also used here (see above).
His-Tag Cleavage with TEV-Protease. Following purifi-
cation, CheA, CheW, CheW, and H6TEV-CF were incubated
with TEV-protease (purification details given above) at a 50:1
His-tagged protein:TEV-protease molar ratio, and the mixture
was shaken at 4 °C overnight and 25 °C for 3 h. Complete
cleavage was confirmed by a gel shift observed by SDS−PAGE.
Cleaved proteins were separated from TEV-protease by being
passed through the equilibrated HisTrap column, collected, and
concentrated with 10 kDa centrifugal concentrators (Amicon);
protein concentrations were measured by the BCA assay
(Thermo Scientific), and proteins were frozen in liquid
nitrogen and stored at −80 °C.
Complex Assembly. Preparation of ternary complexes was
performed as previously described for vesicles15 and PEG17
with some modifications. Briefly, vesicle samples were prepared
by combining the following (in order): autoclaved water, 1 mM
PMSF dissolved in 100% ethanol, phosphate kinase buffer
(PKB) from a 5× stock (the 1× stock being 50 mM KxHxPO4,
50 mM KCl, and 5 mM MgCl2), 12 μM CheA, 24 μM CheW,
30 μM CF (H6CF, H6TEV-CF, or ΔH6CF), and 725 μM
vesicles (prepared as described above). PEG-assembled samples
were made by combining the following (in order): autoclaved
water, 1 mM PMSF, PKB, 12 μM CheA, 20 μM CheW, 50 μM
CF (H6CF, H6TEV-CF, or ΔH6CF), 7.5% (w/v) PEG8000
[from a 40% (w/v) stock], and 4% (w/v) D-trehalose [from a
40% (w/v) stock]. Metal-assembled samples were prepared
under protein and buffer conditions identical to those
optimized for vesicle assembly, except that vesicles were
replaced with metal salts (NiCl2·6H2O, ZnCl2 anhydrous,
CuCl2·2H2O, MnCl2·4H2O, and CoCl2·6H2O, all obtained
from Sigma-Aldrich) prepared at ∼1 mM in autoclaved Milli-Q
H2O. Metal stock concentrations were verified before being
used (see below).
Once combined, samples were incubated in a 25 °C water
bath for 4 h or overnight before use. To measure kinetics of
assembly, both activity and sedimentation (below) were
measured at time points immediately following addition of all
complex components.
Activity and Binding Assays. Kinase activity was
measured using an enzyme-coupled ATPase assay that couples
NADH oxidation to consumption of ATP.15,23,24 Briefly,
activity measurements were conducted immediately following
a 100-fold dilution of assembled complexes into PKB
containing 55 μM CheY, 2.2 mM phosphoenolpyruvate, 4
mM ATP, 250 μM NADH, and 20 units of PK/LDH enzyme
(Sigma-Aldrich). The background activity of CheY under
identical conditions in the absence of the complex was
subtracted before calculation of kinase activity. The kinase
activity (inverse seconds) was determined from the linear
change in absorbance at 340 nm [d[ATP]/dt = −6220(dA340/
dt)] over 1.5 min. Total activity is based on the full amount of
CheA in the sample (12 μM), while the specific activity
considers only the amount of CheA in the complex, based on
quantification from the sedimentation assay (below).
The amount of bound protein was determined with a
sedimentation assay performed at 25 °C in a benchtop
ultracentrifuge (Beckman TLX, TLA 120.2 rotor, 125000g, 30
min). Typically, a 35 μL aliquot of sample (in either assembled
ternary complexes or individual proteins) was centrifuged.
Following sedimentation, the supernatant was carefully
removed and placed into a clean Eppendorf tube to minimize
contamination of free protein in the pellet containing the
bound fraction of proteins. The pellets were slowly
resuspended to the original volume in autoclaved Milli-Q
H2O and vortexed to homogenize the resuspension. Aliquots of
Total (free plus bound protein, before sedimentation),
Supernatant (free protein), and Pellet (bound protein) were
subjected to SDS−PAGE (12.5% acrylamide) and stained with
Gel-code Blue (Pierce Chemical Co.). Gels were imaged by
densitometry with a Gel Doc EZ Imager (Bio-Rad), and the
integrated intensities were analyzed with ImageJ.25 The bound
concentrations were computed as (Ipellet/Itotal)[protein]total for
each protein to be quantified. For excess CheA and CheW
conditions used in this study, quantification of bound protein
by the pellet was more reproducible than Itotal − Isupernatant. Gels
included two additional lanes of the Total sample diluted 6- and
12-fold such that a calibration curve from three intensities for
known concentrations could be calculated. The y-intercept was
then subtracted from each integrated intensity to correct for the
gel background intensity and more accurately estimate the
fraction of protein bound in a complex.
Determination of Metal Concentration. Metal concen-
trations of the ∼1 mM aqueous metal stocks (NiCl2, ZnCl2,
CuCl2, MnCl2, and CoCl2) and the amounts of metal bound to
H6CF (alone or in complex) were measured using a
PerkinElmer Optima DV4300 inductively coupled plasma
optical emission spectroscopy (ICP-OES) instrument. Metal
standards (TraceCERT by Sigma-Aldrich) were used to
produce a calibration curve for each metal at 0.1, 0.2, 0.75, 1,
2, and 10 ppm. Metal stocks were diluted 100-fold, and
protein/metal samples were diluted 10-fold into Milli-Q water
that was also used to blank the instrument. Protein samples
were prepared by overnight incubation of 30 μM H6CF (alone
or with 12 μM CheA and 24 μM CheW) with the metals that
produced active complexes at optimal concentrations (180 μM
NiCl2, 300 μM ZnCl2, or 360 μM CoCl2) in a 25 °C water
bath. Aliquots of these samples were then subjected to
ultracentrifugation (60K rpm for 30 min at 25 °C) to separate
large metal−protein complexes from unbound protein and
metal in the supernatant. Bound protein and metals in the
pellet were carefully resuspended to the initial volume in Milli-
Q water. The entire resuspended pellet was used for ICP-OES
analysis, so that any chunks of protein pellet were still part of
the sample that was measured.
SEC−MALS. Size exclusion chromatography and multi-angle
light scattering (SEC−MALS) were used to monitor metal-
mediated complex formation. The SEC instrument is coupled
to an 18-angle static light scattering detector (DAWN
HELEOS-II), a dynamic light scattering detector (Wyatt-
QELS), and a differential refractometer (Optilab T-rEX, Wyatt
Technology). Proteins were injected onto a TSKgel
G2000SWXL column maintained at 4 °C and pre-equilibrated
overnight with PKB buffer (pH 7.0) kept on ice. Typical
injections were 75 μL of 0.5−3 mg/mL protein. Data were
collected every second for 30 min at a flow rate of 0.5 mL/min.
Protein elution was monitored at A280 and A214, in addition to
static and dynamic light scattering. The accompanying ASTRA
VI software was used to determine molar mass, peak
polydispersity, and ultraviolet (UV) peak areas for all individual
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peaks and the entire elution to determine the percent loss in a
precolumn 0.22 μm filter.
Electron Cryo-Tomography (ECT). Samples were pre-
pared by mixing protein assemblies (as above) with a bovine
serum albumin-treated 10 nm colloidal gold solution (Cell
Microscopy Core, Utrecht University, Utrecht, The Nether-
lands). After being briefly vortexed, 3 μL mixtures were applied
to freshly plasma-cleaned R2/2 copper Quantifoil grids
(Quantifoil Micro Tools). Blotting and plunge freezing in
ethane were performed for approximately 1 s with a Leica
EMGP instrument (Leica microsystems, Wetzlar, Germany),
set at 20 °C and 95% humidity. Grids were stored in liquid
nitrogen until they were imaged. Data were collected on a Titan
Krios transmission electron microscope from Thermo Fisher
Scientific (formerly FEI; Hillsboro, OR) with a field emission
gun operating at 300 kV. The microscope was equipped with a
Gatan (Pleasanton, CA) image filter and a Gatan K2 Summit
direct electron detector. Data were acquired using Tomography
version 4.0 (Thermo Fisher Scientific) in batch mode. Tilt
series for PEG and Ni(II)-assembled H6CF ternary complexes
were collected at nominal magnifications of 42000× and
33000×, respectively. A discontinuous tilt scheme was used for
imaging, taking images from 0° to −60° followed by 0° to 60°
with a 2° tilting increment. The cumulative dosage for each tilt
series was 80 e/A2. Defocus was set to −8 μm. The tilt series
for Ni(II)-assembled H6CF (without CheA or CheW) and
PEG-assembled ΔH6CF complexes were collected using the
same tilt scheme but at a defocus of −300 nm with a volta
phase plate (VPP) (Thermo Fisher Scientific). The VPP was
heated to 225 °C and activated for 80 s before each tilt series
aiming to generate an approximate phase shift of 90°.26 An
extra 5 s of conditioning time was applied between each tilt
image. All images were acquired using the low-dose routine
integrated in the Tomography software. Drift correction and tilt
series alignment were performed with software package
IMOD.27,28 Tomograms were reconstructed using both
weighted back-projection (WBP) and nine iterations of
simultaneous iterative reconstruction (SIRT). PEET was used
for subvolume averaging.29 Visualization and image analysis
were performed with ImageJ and Chimera.25,30
■ RESULTS
Divalent Metals Restore Chemoreceptor Ternary
Complex Formation and Function. Under conditions
similar to those used to form functional complexes of aspartate
receptor CF, CheA, and CheW with templating vesicles, we
have discovered that some divalent metals are sufficient to
restore function, with no requirement for vesicles. A series of
metal titrations reveal the conditions needed to restore both
kinase activity of CheA (measured with an enzyme-coupled
ATPase assay, using the native phosphoryl acceptor protein
CheY) and ternary complex formation (measured with
sedimentation assays). Five divalent metal chlorides were
tested (NiCl2, ZnCl2, CoCl2, CuCl2, and MnCl2) at
concentrations ranging from 0 to 540 μM while protein
concentrations were kept constant at levels that promote
maximal incorporation of CF into functional complexes [30 μM
CF with excess CheA (12 μM) and CheW (24 μM)]. As shown
in Figure 1, NiCl2 promotes active complex formation at the
lowest concentrations, with maximum kinase activity reached at
180 μM NiCl2. The optimal ZnCl2 concentration for kinase
activity is 300 μM, and the total kinase activity is 90% of the
highest observed for NiCl2. While CoCl2 also produced active
complexes in this titration series, the highest kinase activity
(reached at 360 μM CoCl2) is only 50% of that of the optimal
NiCl2 sample. Thus, the relative efficiencies of these metals for
promoting assembly of functional complexes decrease as
follows: NiCl2 > ZnCl2 > CoCl2. Interestingly, the
sedimentation trends for CF, CheA, and CheW with each
metal titration track mostly with the respective onset of activity
(Figure S1). For example, NiCl2-assembled complexes show
both activity and sedimentation beginning at low NiCl2
concentrations, and ZnCl2-assembled complexes show nearly
zero sedimentation until 180 μM ZnCl2, where activity is first
observed. Furthermore, maximal sedimentation of CF, CheA,
and CheW is reached for most cases under conditions that give
maximal activity, and the CoCl2 titration reaches activity and
sedimentation of only 50% of those of the optimal NiCl2
sample. Thus, three divalent metals restore the ability of the
chemotaxis receptor CF to assemble with CheA and CheW into
sedimentable complexes that activate the kinase CheA.
Interestingly, NiCl2 concentrations of >180 μM are clearly
detrimental to kinase activity, and sedimentation of CF
increases an additional 15%; CheA and CheW sedimentations
remain constant (Figure S1). In contrast, ZnCl2 and CoCl2
cause an only modest decrease in activity at high concentrations
(and no significant additional sedimentation).
Neither CuCl2 nor MnCl2 restored formation of active
complexes. Kinase activity throughout the titration is similar to
that of the proteins with no metal (<1 s−1). Furthermore, all
samples with CuCl2 and MnCl2 also had very low protein
sedimentation values of <15%, again similar to levels for the no-
metal control, with the exception of CuCl2 and CheA. At high
Figure 1. Three divalent metals promote kinase activity at different
optimal metal concentrations. All experiments use excess CheA and
CheW, under conditions optimized for maximal incorporation of CF
into complexes with maximal kinase activity (30 μM H6CF, 12 μM
CheA, and 24 μM CheW). Additions of NiCl2 (●), ZnCl2 (▲), or
CoCl2 (◆) each promote kinase activity, with NiCl2 promoting the
highest activity, followed by ZnCl2 and then CoCl2. CuCl2 (○) and
MnCl2 (△) do not promote activity: activity comparable to that of the
no-metal control is observed at all metal concentrations. As a positive
control, PEG-mediated samples were run in parallel, with typical total
kinase activities of ∼11 s−1. Comparisons of specific kinase activity
(per bound CheA) among PEG-, vesicle-, and NiCl2-mediated
assemblies are plotted in Figure 2B. Arrows denote maximally active
conditions used for further studies, including metal:protein stoichi-
ometry measurements listed in Table 1. Activities are averages of four
to eight replicates measured on two or three days; error bars indicate
±one standard deviation. For this plot, measurements on each day
were averaged, and the averages for all days were then combined, with
propagation of the errors.
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CuCl2 concentrations, nearly all of CheA sedimented (data not
shown). Because there is no appreciable kinase activity or
sedimentation of CheW and H6CF, we can conclude that
CuCl2 is most likely causing aggregation of CheA.
Measurements of bound metals indicate that the active
complexes have metal:protein stoichiometries close to 1:1
[Ni(II) and Co(II)] and 3:1 [Zn(II)]. The metal ion
concentrations bound to CF were determined using inductively
coupled plasma optimal emission spectroscopy (ICP-OES), in
samples of active complexes (prepared with CheA and CheW)
as well as CF alone. Metals producing active complexes lead to
sedimentation of both CF alone and CF with CheA and CheW
(with the exception of CoCl2 + CF alone, which does not
sediment). Samples were prepared with each metal at the
optimal concentration based on the activity data (Figure 1,
arrows) and incubated for long assembly times that maximize
kinase activity (>4 h). The bound protein (CF alone or in
complex with CheA and CheW) and metal were separated from
free protein and metal by ultracentrifugation. Resuspended
pellets were then analyzed for metal content by ICP-OES and
protein content by SDS−PAGE (via comparison to a CF
standard measured by the BCA assay). Unfortunately, we were
unable to implement sulfur quantification by ICP-OES, which
would have enabled measurement of a more accurate
metal:protein ratio as the number of sulfur atoms per CF is
known. As listed in Table 1, CF alone and CF in complex have
nearly identical stoichiometries for Ni(II) and Co(II), which
suggests that metals bind similarly to CF in both cases.
Moreover, the calculated stoichiometries are both close to one
metal ion per CF monomer. In contrast, Zn(II) exhibited both
a higher and a more variable stoichiometry of 3.8 Zn(II) per CF
alone and 3.1 per CF in complexes. Thus, for all three metals,
we can conclude that a large excess (6−12 equiv) is necessary
to drive assembly to maximally active CF ternary complexes,
but only a fraction of metal is directly involved in the assembly.
All further studies were performed on Ni(II)-assembled
samples at 180 μM NiCl2.
The Receptor His-Tag Is Essential for Metal-Mediated
Assembly. We hypothesized that the His-tag could be
involved in the metal-mediated assembly of functional chemo-
receptor complexes, perhaps via stabilization of CF dimers or
oligomers. To test this, we engineered a variant of the CF
construct (henceforth called H6CF for the sake of clarity) by
inserting the recognition and cleavage sequence for TEV-
protease after the His-tag (H6TEV-CF). TEV-protease cleavage
of H6TEV-CF yields ΔH6CF, with the native CF sequence plus
a single glycine at the N-terminus. For each version of CF
(H6CF and H6TEV-CF with His-tags and ΔH6CF with no His-
tag, as shown in Figure 2A), we tested the assembly of ternary
complexes with CheA and CheW by three in vitro methods
[vesicles, PEG, and Ni(II)] and measured both the kinase
activity and protein stoichiometry of sedimented complexes.
The three proteins together in buffer with no vesicles, PEG,
or divalent metal show low kinase activity (Figure 2B, None)
and <15% binding (not shown). We had previously observed
variable levels of kinase activity for H6CF, CheA, and CheW
assembled in the absence of vesicles, PEG, or added metals and
realized H6CF may contain variable amounts of Ni(II), stripped
from the NTA affinity column during purification.31 We
incorporated a 5 mM EDTA treatment step into all
purifications, following elution of protein from the column,
and this EDTA is removed in the subsequent dialysis step (see
Materials and Methods). Thus, the low level of activity and
sedimentation observed in the absence of vesicles, PEG, or
metal (Figure 2B, None) is not due to adventitious Ni(II) but
presumably reflects the low stability of these complexes formed
with the truncated CF.
As shown in Figure 2B, both H6CF and H6TEV-CF
complexes are functional with all assembly methods, indicating
that the TEV insertion does not interfere with assembly of
functional CF complexes. As anticipated, removing the His-tag
results in no kinase activity and background levels of protein
binding for both vesicle and Ni(II) assembly methods,
demonstrating that the His-tag is required for metal-mediated
assembly.
The native stoichiometry of chemoreceptor arrays is thought
to be 6:1:2 receptor:CheA:CheW.9,10 As shown in Figure 2C,
all active complexes of the different constructs assembled with
vesicles, PEG, or Ni(II) display near-native stoichiometries.
The variation in CheW (ranging from 2.1 to 3.0) may be due to
weak staining of CheW, resulting in less accurate quantification.
Overall, the stoichiometries are consistent with the nativelike
architecture of PEG arrays, which have high CheA occupancy
observed by electron cryotomography.12 Thus, PEG mediates
assembly via molecular crowding that does not require the His-
tag; both vesicle and Ni(II) assembly require the His-tag to
mediate assembly of complexes with comparable kinase activity
and protein stoichiometry.
Metal-Mediated Complexes Form Arrays with Native-
like Architecture. Chemoreceptor complexes with CheA and
CheW form an extended lattice of hexagonal arrays located
within the bacterial inner membrane that is responsible for
ensuring a sensitive and integrated response to chemical
gradients. Because ternary complex formation and kinase
activity have been observed in the absence of arrays,32−34 we
used electron cryotomography (ECT) to assess the structural
features and homogeneity of the metal-mediated complexes.
ECT images of Ni(II)-mediated H6CF ternary complexes
prepared under conditions leading to maximal activity reveal
clear high-contrast hexagonal lattices (Figure 3A). With 12 nm
center-to-center spacing between hexagons, these are indis-
tinguishable from in vivo arrays and from our other in vitro
assemblies formed with templating vesicles and PEG-mediated
crowding.12 Furthermore, isosurface averages extracted from
the Ni(II)- and PEG-mediated tomograms are remarkably
similar to the electron density from in vivo intact receptors
(Figure S2). Interestingly, Ni(II)-mediated arrays also form the
sandwichlike structures seen with PEG (Figure 3B). This
architecture is likely necessary to stabilize the membrane-
Table 1. Stoichiometries of Metal Binding to CF Measured
by ICP-OESa
metal addedb metal bound to CF alonec metal bound to CF in complexd
Ni(II) 1.2 ± 0.04 1.1 ± 0.05
Zn(II) 3.8 ± 0.16 3.1 ± 0.12
Co(II) NDe 1.1 ± 0.15
aData are averages ± one standard deviation for the number of metal
ions bound per CF monomer from 10 independent ICP-OES
measurements of each metal. bMetal added at concentrations found
to give maximally active complexes (Figure 1, arrows). cSamples
contain 30 μM CF. dSamples contain 30 μM CF, 12 μM CheA, and 24
μM CheW. eCoCl2 with CF alone does not sediment, and thus, metal
content could not be measured.
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proximal ends of the long CF in the absence of organization by
a membrane.
To further investigate the structural similarities between
arrays assembled by these methods, we measured the baseplate
distances between CheA/CheW layers for three assemblies that
formed sandwiches. Figure 3C, a plot of the intensity of the
three-dimensional volume of the side view for Ni(II)-mediated
H6CF, PEG-mediated H6CF, and PEG-mediated ΔH6CF
sandwiches (examples in Figure 3D−F) reveals identical
distances of 33 nm between baseplates. Given an approximate
H6CF receptor length of ∼21.8 nm (145 residues, assuming
they are all α-helical) from the N-terminus to the membrane-
distal tip, this 33 nm sandwich thickness predicts that CFs from
each side of the sandwich overlap with each other in the central
∼10.6 nm region. This may be consistent with the disorder
(low electron density) observed in the approximately central
one-third of the sandwich, as seen in a side view of the
isosurfaces of the electron density calculated by subvolume
Figure 2. Characterization of in vitro-assembled ternary complexes reveals the receptor His-tag is required for metal-mediated assembly of active
complexes with nativelike stoichiometry. (A) Cartoon depicting constructs tested to determine the role of the His-tag (H6, red box) in metal-
mediated assembly of active complexes. (B) Specific activity of CheA kinase assembled with CheW and His-tagged receptor (black for H6CF or gray
for H6TEV-CF) or non-His-tagged receptor (striped for ΔH6CF). Activities are averages of four to eight replicates measured on two to four days;
error bars indicate ±one standard deviation. (C) Stoichiometries for active complexes determined as the ratio of proteins in the sedimented
complexes. The ∼25−28 μM sedimented CF was set to 6 for calculations of the relative amounts of bound CheA (blue) and CheW (cyan), based on
ratios of band intensities in SDS−PAGE of sedimented complexes. Horizontal solid and dashed lines correspond to native 6:1:2 molar
stoichiometries. Stoichiometries are averages of two to four replicates measured on two to four days; error bars indicate ±one standard deviation.
Error bars are either large or missing for CheW stoichiometries in PEG complexes, because of gel distortions from PEG in the CheW molecular
weight range.
Figure 3. Ni(II)-mediated functional complexes form arrays with nativelike architecture similar to arrays formed by molecular crowding (PEG-
mediated arrays). Tomographic slices of (A) Ni(II)-mediated H6CF and (B) PEG-mediated H6CF show both top-down patches of hexagonal arrays
(white arrows) and side view sandwichlike structures (black arrows) made from two layers of CF with overlapping N- and C-termini that are
sandwiched between baseplates of CheA and CheW on the outside. Scale bars are 50 nm, and insets show enlarged subvolume averages of the
hexagonal array with the canonical 12 nm center-to-center spacing (dotted lines in the insets of panel A and B are 12 nm) that is identical to that of
in vivo arrays.8,12 (C) Comparison of intensities of the three-dimensional volume reveals that sandwich thicknesses for three sample types are all close
to 33 nm. Five separate cubes containing sandwiches of similar proportions were averaged for each sample (Figure S3). (D−F) Example two-
dimensional tomographic slices of sandwiches from Ni(II)-mediated H6CF, PEG-mediated H6CF, and PEG-mediated ΔH6CF ternary complexes
used to determine intensity across the sandwich length. Scale bars are 20 nm.
Biochemistry Article
DOI: 10.1021/acs.biochem.7b00698
Biochemistry 2017, 56, 5874−5885
5879
averaging of tomograms for Ni(II)- and PEG-mediated H6CF
(Figure S2). Remarkably, the similarity in baseplate distances
indicates that the overlap interactions that stabilize the
sandwich assembly do not depend critically on what stabilizes
the complexes (metal or PEG) or on the sequence of the N-
termini (H6CF vs ΔH6CF) that are present in the overlap
region. Finally, the similarity in the architecture of the PEG-
assembled H6CF and ΔH6CF arrays indicates that the ECT
resolution is not sufficient to detect whatever differences in
structure and dynamics account for the 2-fold difference in
kinase activity (Figure 2B) between these samples.
Insight into Array Assembly and Properties. The
results presented above suggest that metal binds to the His-tag
of H6CF and somehow stabilizes formation of the functional,
nativelike array with CheA and CheW. Within the native
architecture, what interactions could be stabilized by metal
bridging two His-tags? The N-terminal His-tags are adjacent
within the H6CF dimer. In contrast, His-tags on two different
dimers are not adjacent in the trimer of dimers (they are >65 Å
apart in the ECT-derived structural model, Protein Data Bank
entry 3JA6),10 and His-tags on the two H6CF layers are not
likely to be adjacent in the sandwich (they are on opposite sides
of the ∼10 nm overlap region). Thus, it seems likely that metal
binding bridges two His-tags within a H6CF dimer, and
stabilization of the dimer drives assembly of the functional
array. To investigate this, we monitored the formation of metal-
mediated complexes of H6CF using SEC−MALS. The three
component proteins and their complexes can be partially
resolved via SEC, with the largest complexes and proteins
eluting first, but SEC does not yield accurate molecular weights
for variably shaped proteins like the long rod-shaped chemo-
receptor. The MALS data enable the determination of
hydrodynamic properties for better estimation of MW.
However, MW estimation is not accurate for overlapping
peaks or high-MW complexes that elute near the void volume
and are highly polydisperse. SEC−MALS was used to monitor
formation of complexes of H6CF alone (Figure 4) and of
functional complexes of H6CF with CheA and CheW (Figure
5).
Complex formation of H6CF alone provided the best means
of assessing the effect of metal on the H6CF monomer−dimer
equilibrium, because H6CF dimer and CheA have overlapping
peaks (see Figure 5B). We anticipate that binding of Ni(II) to
the H6CF His-tag is similar in the presence and absence of
CheA and CheW, because ICP-OES indicates 1:1 binding in
both cases. As discussed above, incubation of H6CF alone with
NiCl2 results in sedimentable aggregates. Apparently, these
aggregates can become too large to pass the 0.22 μm
precolumn filter, as the total eluted protein was observed to
decrease over the time course of the experiment. Figure 4A
shows the overlaid chromatograms from the time course series,
all scaled to the same total integrated peak area. The amount of
aggregate lost in the precolumn filter (dashed line in Figure 4B)
was calculated from the decrease in area with each injection. To
quantify the fraction of monomer, dimer, and oligomer, elution
time ranges were set at the points of minimum A280 between
peaks (Figure 4A, gray vertical lines at 10, 11.7, 12.8, and 15.5
min), and these peak areas were used to calculate the
percentage of H6CF in monomer, dimer, and oligomer forms
(Figure 4B).
SEC−MALS of H6CF incubated with 180 μM NiCl2 (Figure
4) demonstrates that Ni(II) stabilizes the H6CF dimer. Prior to
the addition of NiCl2, the monomer:dimer ratio is approx-
imately 10:1 (Figure 4, red) based on the integrated UV peak
area ratio of 5.1:1 (area of the dimer peak divided by 2 gives the
dimer concentration). Strikingly, within the minimal time to
add metal to the protein and inject it onto the column (<1
min), there is a significant decrease in the monomer:dimer ratio
to 3.7:1 (Figure 4, orange), which corresponds to a 2.7-fold
decrease in this ratio. At remaining time points, both monomer
and dimer concentrations continue to decrease in parallel,
because of a significant increase in the aggregate fraction
(Figure 4B). The system is not at equilibrium, but the
monomer:dimer ratio remains in the range of 6−8:1, consistent
with Ni(II) stabilization of H6CF dimers.
To understand the mechanism of metal-mediated formation
of functional complexes, we investigated the assembly kinetics
by measuring the onset of kinase activity and sedimentation
immediately after combining the H6CF, CheA, CheW, and 180
Figure 4. Ni(II) stabilizes the H6CF dimer, which in turn favors larger oligomers. (A) SEC−MALS chromatograms of 30 μM H6CF incubated with
180 μM NiCl2, colored by rainbow according to the increasing incubation time. Vertical lines indicate elution time bounds used to distinguish ther
monomer (12.8−15.5 min), dimer (11.7−12.8 min), and oligomers (10−11.7 min). Although identical volumes (75 μL) of the same sample were
injected, some H6CF aggregate was caught in the precolumn filter. Chromatograms are normalized to a value of 1 for the largest peak in the series.
These data are further scaled to the same total area to account for aggregated protein (B, dashed line). (B) The peak areas of the monomer (circle),
dimer (triangle), and oligomers (square) were used to calculate the amount of H6CF in each state for all incubation times. The percent H6CF in
aggregates larger than the 0.22 μm precolumn filter (dashed line) was calculated from the loss of area under the SEC elution curve.
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μM NiCl2. Assembly with either vesicles
24 or PEG (unpub-
lished observations) requires incubation at 25 °C for at least 4 h
before maximal activity is reached. Although the NiCl2
assembly activity similarly achieves maximal activity after 4 h
(Figure 5A), the sedimentation profile shows nearly complete
binding (80−90%) of all three proteins within the first 30 min.
Note that complex formation may continue during the 30 min
centrifugation, whereas the kinase activity measurements take
<2 min; therefore, complete binding occurs at 30−60 min.
Thus, the kinase activity is only 40−60% when the CheA and
CheW incorporation is maximal, which suggests that initially
the three proteins bind quickly but require conformational
changes or rearrangement to reach maximal activity.
We returned to SEC−MALS to monitor complex formation
with NiCl2. First, separate injections of the individual proteins
demonstrate they are well-resolved and that MALS estimates of
the molecular masses are reasonably close to the actual values
(Figure 5B and Figure S4): the 32.7 kDa H6CF elutes at 13.5
min with an apparent MW of 34 kDa (black), the 142.7 kDa
CheA dimer elutes at 11.5 min with an apparent MW of 139
kDa (blue), and the 18.1 kDa CheW monomer elutes at 16 min
with an apparent MW of 18 kDa (cyan). These proteins were
injected at the concentrations used for metal-mediated
assembly (30 μM H6CF, 12 μM CheA, and 24 μM CheW).
The H6CF peak observed at 12 min with an apparent MW of
73 kDa (black) corresponds to the 65.4 kDa dimer but is
hidden under the CheA peak once all proteins are combined.
With all three proteins combined and injected at the same
concentration as the individual injections (Figure 5B, red), the
two peaks of H6CF and CheW move together slightly, which
suggests a possible interaction between the two proteins in
solution or on the column. There is also a small shoulder at 11
min, which is likely to be a small amount of ternary complex
formation, consistent with the <15% sedimentation observed
under these conditions for an identical sample [0 time in Figure
5A, which has no Ni(II)].
To monitor the formation of a complex with time, a large
volume was prepared to enable multiple injections of a single
sample at different time points. While this experiment imparts a
dilution (∼13-fold) from injection to elution, which favors
protein dissociation, dissociation caused by a 100-fold dilution
of vesicle-assembled arrays is much slower than the time scale
of this experiment.24
The first changes observed by SEC during complex assembly
involve primarily H6CF. The difference between the no NiCl2
and <1 min with NiCl2 injections (Figure 5C, red and orange)
is a decrease in H6CF peak height and a corresponding increase
in the intensity of a high-MW species that elutes at 11.1 min.
The latter may consist of only H6CF oligomers, because there is
no significant change in the intensities of the CheA and CheW
peaks. Next, incorporation of CheA and CheW into complexes
with H6CF appears to be nearly complete in 30 min, based on
both the sedimentation data (Figure 5A) showing nearly
complete binding at 30−60 min and the decrease in the
intensities of the CheA and CheW SEC peaks (Figure 5C,
yellow) with no further changes at longer time points. CheA
Figure 5. Kinetics of Ni(II)-mediated assembly of H6CF ternary
complexes. (A) Time course of kinase activity (●) and sedimentation
of H6CF, CheA, and CheW (black, dark blue, and cyan bars,
respectively) combined with 180 μM NiCl2. The zero time point is
before NiCl2 addition. Activity and sedimentation data are normalized
to their respective maxima, achieved at 4 h (maximum total activity of
7.6 s−1, specific activity per bound CheA of 16 s−1, and maximum
sedimentations of 27.0 μM H6CF, 5.8 μM CheA, and 13.6 μM
CheW). Activities and sedimentation percentages are averages of two
(sedimentation) and four (activity) replicates measured on 2 days;
error bars indicate ±one standard deviation. (B) SEC chromatograms
of separately injected H6CF (black), CheA (blue), and CheW (cyan)
at concentrations used for assembly (Figure 1, legend), as well as a
single injection of all three in solution without NiCl2 (red). Molecular
masses estimated from multi-angle light scattering (MALS) are
indicated and are reasonably consistent with the molecular weights
of dimeric CheA (142.7 kDa), dimers and monomers of H6CF (32.7
kDa), and CheW (18.1 kDa). (C) SEC chromatograms of H6CF,
CheA, and CheW incubated with NiCl2, colored by rainbow according
to increasing incubation times. A high-MW complex of H6CF, CheA,
and CheW (11 min elution time) that forms in low yield in the
absence of NiCl2 (0 min sedimentation in panel A and red in panels B
and C) and in high yield at early incubation times (30 and 60 min in
panel A and yellow and green in panel C) sediments but does not have
Figure 5. continued
high kinase activity. Maximal kinase activity appears to correlate with
formation of a higher-MW complex indicated by the arrow (near void
volume at a 10.5 min elution time). All chromatograms in each plot are
normalized to a value of 1 for the largest peak in the series.
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and CheW are presumably incorporated into a complex with
H6CF that elutes as a large SEC peak at 11.1 min. While the
elution time is the same as that of the small shoulder seen
immediately after the addition of NiCl2 (Figure 5C, orange),
this peak is highly polydisperse and thus likely contains a
mixture of species with different molecular weights. At longer
time points (1−4 h, green to blue to violet, Figure 5C), a
second peak emerges at an even higher MW (arrow, 10.8 min)
and the H6CF peak continues to decrease to nearly zero
intensity. These changes coincide with the assembly reaching
maximum kinase activity, as shown in Figure 5A. The H6CF,
CheA, and CheW peaks remaining at 4 h are consistent with
the assembly conditions: large amounts of free CheA and
CheW because these are added in excess and only ∼20% free
H6CF, consistent with sedimentation analysis that typically
shows ∼10−15% free H6CF after assembly.
■ DISCUSSION
Here we report a novel method for assembly of the aspartate
chemoreceptor cytoplasmic fragment (CF) into nanoarrays
through metal-mediated His-tag dimerization and compare
these to other in vitro nativelike arrays. Functional complexes of
CF, CheA, and CheW form upon addition of specific divalent
metals and assemble into an extended hexagonal lattice that
exhibits the widely conserved,5,35 native 12 nm center-to-center
spacing (Figure 3). Intact chemoreceptor arrays are normally
stabilized by a combination of anchoring in the membrane and
cytosolic binding of CheA and CheW in rings at the
membrane-distal cytoplasmic tip of the receptor. In current
structural models of the complex, the long (∼200 Å)
cytoplasmic domain has protein−protein interactions with
itself, CheA, and CheW only at its membrane-distal end, so the
constraints imposed by its transmembrane and periplasmic
domains are likely critical to the stability of the array. The
necessary membrane-proximal stability to form CF arrays can
be achieved with a membrane mimetic (templating vesicles)15
or with a sandwich architecture produced with PEG17 or
divalent metals (this work). Importantly, all three in vitro
preparations with CF yield high CheA occupancy and native
stoichiometry (Figure 2C), although PEG arrays have
previously been shown to lack the alternating hexagons of
CheA observed for in vivo arrays.12 Measured CheW
stoichiometries of 2 monomers per 6 CF monomers in these
assemblies provide further evidence of CheW-only rings that
are proposed to provide structural integrity to the array.9,10
Chemoreceptors have been observed to form alternate non-
native structures in the absence or with insufficient quantities of
their cytoplasmic binding partners, CheA and CheW. In
particular, so-called “zippers” with interdigitation of the
receptor cytoplasmic tips have been reported for overexpressed
receptors in vivo,4,36 reconstituted intact receptors,37 and CF
assembled on templating vesicles.24 A more detailed analysis of
the overexpressed intact receptors revealed hexagonal packing
with 9 nm center-to-center spacing that is distinct from that of
the wild-type 12 nm arrays observed in both membrane-bound
and sandwich architectures.12 In this study, we have identified
yet another structure formed by CF in the absence of CheA and
CheW, double-stranded fibrils. ECT images (Figure S5A)
demonstrate that H6CF and NiCl2 in the absence of CheA and
CheW produce a mixture of nonspecific aggregates and fibrils
with uniform 7 nm widths but varying lengths (40−105 nm).
Interestingly, these fibrils and aggregates are at least partially
reversible: addition of CheA and CheW after preincubation of
H6CF with NiCl2 can produce complexes with kinase activity
that is 60−80% of that of normal complexes assembled by
adding NiCl2 last (Figure S5B).
In contrast to the non-native “zippers” that form with
cytoplasmic tips interdigitated in the center in the absence of
sufficient CheA and CheW, “sandwiches” have receptors
oriented in the opposite direction: cytoplasmic tips interact
with CheA/CheW rings on both surfaces of the sandwich,
forming hexagonal arrays with the canonical 12 nm center-to-
center packing. Although sandwiches are not the native
architecture for the E. coli aspartate receptor used in this
study, similar cytoplasmic arrays exhibiting both 12 nm
hexagonal lattices and sandwich architectures are observed for
cytoplasmic chemoreceptors (lacking transmembrane domains)
from a variety of bacteria and archaea, including Vibrio
cholerae,19 Rhodobacter sphaeroides,18 and Methanobacterium
formicicum.38
The observed metal dependence of assembly is consistent
with the proposed His-tag dimerization mechanism. The
relative efficiency of the divalent metals in promoting active
complex formation [Ni(II) > Zn(II) > Co(II)] follows the
relative affinities of these metals for peptides containing
multiple His residues.39 This is consistent with preliminary X-
ray absorption spectroscopy (XAS) data (H.-T. Huang and M.
J. Maroney, unpublished observations), suggesting that the
Ni(II) bound to H6CF is coordinated by six ligands, including
multiple histidines. Importantly, knowing Ni(II) is six-
Figure 6. Model of array assembly by Ni(II)-mediated His-tag dimerization. Cartoon representation showing progression of assembly starting with
CF monomers (side view, gray bars) rapidly forming dimers upon Ni(II) (black dots) binding to CF His-tags (red line). CheA dimers (blue) and
CheW monomers (cyan) bind to stabilized H6CF dimers to capacity within 30 min to 1 h. Binding of a CheA dimer and four CheWs drives assembly
of a pair of trimers-of-receptor dimers into a core unit, which is likely further stabilized as a sandwich. At longer time points (≥4 h), the assemblies
form hexagons and larger arrays with alternating CheA/CheW and CheW-only rings.
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coordinate and therefore paramagnetic suggests it may be
possible to obtain distance constraints with paramagnetic
relaxation enhancement NMR experiments involving compar-
ison to the diamagnetic Zn(II) assembly that has an identical
array architecture as determined by ECT (Figure S6). This
could provide critical structural information in the overlap
region of the sandwich where electron density is lost in ECT
(Figure S2)
Characterization of the metal-mediated assembly of CF
arrays by activity assays, sedimentation assays, and SEC−MALS
allows us to propose a model for the mechanism of this
assembly (Figure 6) and yields new insights into the assembly
and properties of native chemoreceptor arrays. The fast (<1
min) initial increase in the dimer fraction (Figure 4) indicates
that assembly begins with the stabilization of CF dimers, most
likely by metals bridging two His tags. Subsequently, CheA and
CheW are incorporated with metal-stabilized CF dimers into
sedimentable complexes. However, binding of CheA and CheW
is complete within 30−60 min, forming sedimentable
complexes smaller than the fully active complexes that form
in 4 h (Figure 5A,C). While our data cannot distinguish the
exact size of these initial smaller complexes, Figure 6 shows one
possibility that includes full binding of CheA and CheW into a
sandwich of two core units, each containing 12 CFs (two
trimers of dimers), bridged by one CheA dimer, and also
containing four CheW monomers. It is unclear what changes
occur between 1 and 4 h to yield larger complexes with higher
activity that ultimately have the canonical hexagonal
architecture. In one SEC−MALS series (Figure 5C), there
was a small increase in the level of CF binding, while in another
series (not shown), there was a small increase in the level of
binding of all three proteins. We propose that building to larger
complexes with maximal activity likely involves assembly of
core units into hexagons that coalesce to form larger arrays and
likely also involves additional binding of some CF, CheA, and/
or CheW to unoccupied sites in the coalesced array, as well as
rearrangement of CheA and CheW into the native pattern that
maximizes CheA binding in alternating hexagons of CheA/W12
and only CheW. In any case, it appears that protein−protein
interactions beyond those in the core unit are required for full
activity.
The insights from this novel in vitro assembly mechanism
may also shed light on how these remarkable arrays form in the
cell. Briegel and others12 proposed the following model for in
vivo array assembly: (1) receptors dimerize, (2) three receptor
dimers form a trimer of dimers, (3) pairs of receptor trimers of
dimers are bridged by a CheA dimer and bind two CheWs to
form the core unit, (4) three core units coalesce to form
hexagons containing CheA and CheW, and (5) the array grows
through binding of additional core units or of additional CheA/
W-filled hexagons. Our data support the importance of the
initial receptor dimerization in the membrane, because metal-
mediated stabilization of the CF dimer is sufficient to drive
array assembly. We see no evidence of formation of discrete
trimers of CF dimers in the absence of CheA and CheW and
instead observe that CF dimers form various oligomers and
large aggregates, consistent with prior observations in vivo.4 We
propose that in the absence of a stabilizing membrane or
membrane mimetic, CheA and CheW are required to mediate
assembly of receptor dimers into trimers of dimers. These are
then bridged by CheA dimers into core units that also bind four
CheWs. This would satisfy all of the receptor binding sites (two
receptor−CheA interfaces, four receptor−CheW interfaces, and
six receptor−receptor interfaces) and thus prevent non-native
interactions that lead to aggregation both in vitro and in vivo.
Our data support incorporation of four CheWs into the core
unit because there is little additional CheW binding upon
assembly of larger arrays. Two of the four CheWs in the core
unit are weakly bound (lacking the CheA−CheW protein−
protein interaction) and thus would likely be lost during
purification of core complexes with full-length receptors in
nanodiscs40 (which contained two CheWs per core unit).
These weakly bound CheWs are more likely to be retained
under excess CheW conditions as in our CF assembly
conditions. It seems likely that the additional two weakly
bound CheWs in the core unit would increase the rate of
assembly and, as previously suggested,9 increase the stability of
the array. Finally, we propose that assembly of core units into
hexagons is required to achieve maximal kinase activity.
Several important differences are expected between the His-
tag-mediated assembly of arrays of receptor fragments and in
vivo assembly of membrane-bound chemoreceptor arrays.
Studies of assembly of CF arrays cannot provide insights into
the effects of the missing periplasmic, transmembrane, and
HAMP domains, or the effects of ligand binding.41 Assembly of
core units, hexagons, and arrays likely occurs faster in vivo
because of alignment of receptors in the membrane facilitating
encounters by two-dimensional diffusion within the plane of
the membrane rather than by three-dimensional diffusion.
Interestingly, although the cellular concentrations of the E. coli
chemotaxis array proteins have been shown to vary significantly
with strain and growth conditions, the protein ratios in the cell
remain consistent at 2.9 receptors to 1 CheA to 1.2 CheWs.42
This excess CheA and CheW is similar to the conditions of our
His-tag-mediated assembly of CF arrays, containing a ratio of
2.5 CF to 1 CheA to 2 CheWs. Although in vitro assembly does
not duplicate the crowded conditions in the cell that alter
protein diffusion rates and affinities, it may be possible to
investigate whether excess CheA and CheW promote assembly
as previously suggested.12
Assembly of large multiprotein complexes in vitro that retain
native structure and function is a challenging but essential step
in understanding how protein machines operate in the cell. We
have demonstrated the value of His-tags to mediate
dimerization and stabilize homogeneous, functional assemblies
of chemotaxis signaling proteins. This dimerization strategy
may prove to be valuable for assembly of other complex
systems. Indeed, Cornelissen, van Hest, and co-workers
discovered that metal-ion-induced stabilization can be used to
stabilize a capsid assembly that is otherwise unstable in the
absence of a high negative charge from either encapsulated
RNA or low pH. Via the simple addition of divalent metals to
the His-tagged cowpea chloric mottle virus capsid protein,
capsid structures with native particle size form at neutral pH
and can be used to encapsulate other proteins or drugs.43,44
Their model suggests the metal promotes His-tag-to-His-tag
interactions that stabilize the large oligomeric capsid structure.
His-tag-mediated dimerization is a means of stabilizing protein
dimers that is much less perturbing than fusion to a protein
dimerization motif. For example, fusion to a leucine zipper
(LZ) introduces 30−60 residues, which is more perturbing than
a six-residue His-tag and can interfere with assembly of native
complexes. Interestingly, fusion of a 45-residue LZ to the
chemotaxis receptor CF used in our study restored kinase
activation but perturbed the assembly of native complexes with
CheA and CheW. The LZ-CF assembled into sandwichlike
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particles in the opposite orientation (two CF layers on the
outside of a middle layer of CheA and CheW) that prevented
formation of the native array.45−47 This comparison of LZ- and
His-tag-mediated dimerization of the same system demon-
strates that using the least perturbing means of stabilization
protein interactions can be critical to assembling native
complexes. This approach has significant potential for
application to other multiprotein systems, for the stabilization
of functional complexes with native architecture. His-tags are
widely used, and they are easily introduced at many locations
within a recombinantly expressed protein. This should make it
possible to drive dimerization at a known dimer interface with
minimal perturbation to structure or function, for straightfor-
ward and accurate in vitro studies of the mechanisms of key
processes in the cell.
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■ ABBREVIATIONS
BCA, bicinchonic acid; CF, cytoplasmic fragment of the E. coli
aspartate chemotaxis receptor; DOGS-NTA, 1,2-dioleoyl-sn-
glycero-3-{[N-(5-amino-1-carboxypentyl)iminodiacetic acid]-
succinyl}; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine;
ECT, electron cryotomography; ICP-OES, inductively coupled
plasma-optical emission spectroscopy; IPTG, isopropyl β-D-1-
thiogalactopyranoside; LZ, leucine zipper; PEG, polyethylene
glycol 8000; PKB, phosphate kinase buffer; PMSF, phenyl-
methanesulfonyl fluoride; SDS−PAGE, sodium dodecyl
sulfate−polyacrylamide gel electrophoresis; SEC−MALS, size
exclusion chromatography−multi-angle light scattering; TEV,
tobacco etch virus; XAS, X-ray absorption spectroscopy.
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